These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 697865)

  • 1. Denaturation of cytochrome P-450 by cyclophosphamide metabolites.
    Marinello AJ; Gurtoo HL; Struck RF; Paul B
    Biochem Biophys Res Commun; 1978 Aug; 83(4):1347-53. PubMed ID: 697865
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclophosphamide modulates rat hepatic cytochrome P450 2C11 and steroid 5 alpha-reductase activity and messenger RNA levels through the combined action of acrolein and phosphoramide mustard.
    Chang TK; Waxman DJ
    Cancer Res; 1993 Jun; 53(11):2490-7. PubMed ID: 8495410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the mutagenicity and teratogenicity of cyclophosphamide and its active metabolites, 4-hydroxycyclophosphamide, phosphoramide mustard, and acrolein.
    Hales BF
    Cancer Res; 1982 Aug; 42(8):3016-21. PubMed ID: 7046914
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of thiols on toxicity and carcinostatic activity of cyclophosphamide.
    Gurtoo HL; Marinello AJ; Berrigan MJ; Bansal SK; Paul B; Pavelic ZP; Struck RF
    Semin Oncol; 1983 Mar; 10(1 Suppl 1):35-45. PubMed ID: 6836326
    [No Abstract]   [Full Text] [Related]  

  • 5. Teratogenicity of cyclophosphamide metabolites: phosphoramide mustard, acrolein, and 4-ketocyclophosphamide in rat embryos cultured in vitro.
    Mirkes PE; Fantel AG; Greenaway JC; Shepard TH
    Toxicol Appl Pharmacol; 1981 Apr; 58(2):322-30. PubMed ID: 7245204
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the mechanism of denaturation of cytochrome P-450 by cyclophosphamide and its metabolites.
    Gurtoo HL; Marinello AJ; Struck RF; Paul B; Dahms RP
    J Biol Chem; 1981 Nov; 256(22):11691-701. PubMed ID: 7298626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation on cyclophosphamide treatment during the preimplantation period. II. In vitro studies on the effects of cyclophosphamide and its metabolites 4-OH-cyclophosphamide, phosphoramide mustard, and acrolein on blastulation of four-cell and eight-cell mouse embryos and on their subsequent development during implantation.
    Spielmann H; Jacob-Müller U
    Teratology; 1981 Feb; 23(1):7-13. PubMed ID: 7245091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of acrolein in cyclophosphamide teratogenicity in rat embryos in vitro.
    Mirkes PE; Greenaway JC; Rogers JG; Brundrett RB
    Toxicol Appl Pharmacol; 1984 Feb; 72(2):281-91. PubMed ID: 6546458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxicity, DNA cross-linking, and single strand breaks induced by activated cyclophosphamide and acrolein in human leukemia cells.
    Crook TR; Souhami RL; McLean AE
    Cancer Res; 1986 Oct; 46(10):5029-34. PubMed ID: 3463409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of in vivo and in vitro murine immune responses by the cyclophosphamide metabolite acrolein.
    Kawabata TT; White KL
    Cancer Res; 1988 Jan; 48(1):41-5. PubMed ID: 3257162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism and binding of cyclophosphamide and its metabolite acrolein to rat hepatic microsomal cytochrome P-450.
    Marinello AJ; Bansal SK; Paul B; Koser PL; Love J; Struck RF; Gurtoo HL
    Cancer Res; 1984 Oct; 44(10):4615-21. PubMed ID: 6380709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of acrolein on phosphoramide mustard-induced sister chromatid exchanges in cultured human lymphocytes.
    Wilmer JL; Erexson GL; Kligerman AD
    Cancer Res; 1990 Aug; 50(15):4635-8. PubMed ID: 2369740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of reactive metabolites in drug-induced teratogenesis.
    Hales BF; Slott VL
    Prog Clin Biol Res; 1987; 253():181-91. PubMed ID: 3432286
    [No Abstract]   [Full Text] [Related]  

  • 14. Antitumor activity of halogen analogs of phosphoramide, isophosphoramide, and triphosphoramide mustards, the cytotoxic metabolites of cyclophosphamide, ifosfamide, and trofosfamide.
    Struck RF; Schmid SM; Waud WR
    Cancer Chemother Pharmacol; 1994; 34(3):191-6. PubMed ID: 8004750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of metabolites of cyclophosphamide in cardiotoxicity.
    Kurauchi K; Nishikawa T; Miyahara E; Okamoto Y; Kawano Y
    BMC Res Notes; 2017 Aug; 10(1):406. PubMed ID: 28807058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of oxazaphosphorines.
    Sladek NE
    Pharmacol Ther; 1988; 37(3):301-55. PubMed ID: 3290910
    [No Abstract]   [Full Text] [Related]  

  • 17. Conversion of 4-hydroperoxycyclophosphamide and 4-hydroxycyclophosphamide to phosphoramide mustard and acrolein mediated by bifunctional catalysis.
    Low JE; Borch RF; Sladek NE
    Cancer Res; 1982 Mar; 42(3):830-7. PubMed ID: 7059981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competitive inhibition of human liver microsomal cytochrome P450 3A-dependent steroid 6 beta-hydroxylation activity by cyclophosphamide and ifosfamide in vitro.
    Murray M; Butler AM; Stupans I
    J Pharmacol Exp Ther; 1994 Aug; 270(2):645-9. PubMed ID: 8071856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of phosphoramide mustard and acrolein, cytotoxic metabolites of cyclophosphamide, on mouse limb development in vitro.
    Hales BF
    Teratology; 1989 Jul; 40(1):11-20. PubMed ID: 2763206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of DNA crosslinks and DNA strand lesions by cyclophosphamide after activation by cytochrome P450 2B1.
    Hengstler JG; Hengst A; Fuchs J; Tanner B; Pohl J; Oesch F
    Mutat Res; 1997 Feb; 373(2):215-23. PubMed ID: 9042403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.